Strategic deployment of CHO expression platforms to deliver Pfizer's Monoclonal Antibody Portfolio

E-ISSN： 1520-6033|33|6|1463-1467

ISSN： 8756-7938

Source： BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol.33, Iss.6, 2017-11, pp. : 1463-1467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Monoclonal Antibody to Human DLK1 Reveals Differential Expression in Cancer and Absence in Healthy Tissues

By Bujak Emil Ritz Danilo Neri Dario

Antibodies, Vol. 4, Iss. 2, 2015-04 ,pp. : 71-87

MDPI

Access to resources Recommend Favorite

Reduced Culture Temperature Differentially Affects Expression and Biophysical Properties of Monoclonal Antibody Variants

By Mason Megan Sweeney Bernadette Cain Katharine Stephens Paul Sharfstein Susan T.

Antibodies, Vol. 3, Iss. 3, 2014-08 ,pp. : 253-271

MDPI

Access to resources Recommend Favorite

Monoclonal Antibody Therapies against Anthrax

By Chen Zhaochun Moayeri Mahtab Purcell Robert

Toxins, Vol. 3, Iss. 8, 2011-08 ,pp. : 1004-1019

MDPI

Access to resources Recommend Favorite

Development of Biodegradable Nanocarriers Loaded with a Monoclonal Antibody

By Gdowski Andrew Ranjan Amalendu Mukerjee Anindita Vishwanatha Jamboor

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3990-3995

MDPI

Access to resources Recommend Favorite

c‐Src‐dependent transactivation of EGFR mediates CORM‐2‐induced HO‐1 expression in human tracheal smooth muscle cells

JOURNAL OF CELLULAR PHYSIOLOGY, Vol. 230, Iss. 10, 2015-10 ,pp. : 2351-2361

John Wiley & Sons Inc

Access to resources Recommend Favorite